Companies in the pharmaceutical industry must shift from L1 (lowest-bid) costing to Life Cycle Cost Analysis (LCCA) to achieve long-term cost optimization, improve decision-making, and enhance sustainability
These certifications reflect the company's continuous commitment to maintaining international standards of environmental sustainability as well as occupational health and safety
Landmark studies have shown that rapid TXA administration can significantly reduce mortality
This strategic initiative aims to accelerate proof-of-concept of pipeline assets by streamlining R&D operations
FDA closes inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad with 2 observations
The investment in land is Rs. 19.85 crore
Caplin Point Laboratories has reported total income of Rs. 564.41 crore during the period ended September 30, 2025
Dr Reddys Laboratories has reported total income of Rs. 8,805.1 crore during the period ended September 30, 2025
Divi's Laboratories has reported total income of Rs. 2,529 crores during the period ended June 30, 2025
Morepen Laboratories has reported total income of Rs. 429.64 crores during the period ended June 30, 2025
Subscribe To Our Newsletter & Stay Updated
